Skip to main content
Caplight Logo









48Hour Discovery

48Hour Discovery

Private
EdmontonHealthcare & Life Scienceshttps://48hourdiscovery.com/

Last Round

Grant

Jun 24, 2025

Total Funding Raised

$3.41M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

48Hour Discovery is a biotechnology company that provides a peptide-based drug discovery platform to accelerate the identification and optimization of therapeutic leads.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

peptide discoveryphage displaydrug discoverycontract research organizationCROhigh-throughput screeningradiopharmaceuticalslead optimizationnext-generation sequencingNGStherapeutic peptidesbiotech servicesdrug discovery platformAI-driven drug discoveryin silico drug design

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

48Hour Discovery Comparables

Compare 48Hour Discovery with similar companies based on industry and business-model similarity.

48Hour Discovery comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Orbit Discovery
84%
20n Bio
83%
ProteinQure
81%

48Hour Discovery Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 24, 2025
DebtJun 24, 2024
GrantMay 8, 2024
GrantJan 23, 2024
GrantJan 1, 2023
Grant
Mar 15, 2021

Key People

Founding team and executive leadership

Rick Finnegan

Chief Executive Officer

Executive Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 1, 2026

    Open roles increased to 16, 2.4x the trailing average.

  • Jul 20, 2026

    Open roles increased to 16, 123% of headcount.

48Hour Discovery Filings

Explore SEC and related filing metadata, where available.

48Hour Discovery filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about 48Hour Discovery's valuation, stock price, and market status.

Is 48Hour Discovery a public or private company?

48Hour Discovery is a private company.

What is the current stock price of 48Hour Discovery?

48Hour Discovery is a private company with no public stock price. No recent secondary market data is available.

How much is 48Hour Discovery worth (valuation)?

Valuation information for 48Hour Discovery is not publicly available.

Can I buy 48Hour Discovery stock?

48Hour Discovery shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was 48Hour Discovery's last funding round?

48Hour Discovery's most recent funding round was Grant on June 24, 2025.

Who are the main investors in 48Hour Discovery?

Key investors in 48Hour Discovery include Consortium Québécois sur la découverte du médicament, National Research Council Canada Industrial Research Assistance Program, National Research Council Canada, Alberta Cancer Foundation, Alberta Innovates.

Will 48Hour Discovery IPO soon?

No public IPO plans have been announced for 48Hour Discovery.

How can I track 48Hour Discovery secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor 48Hour Discovery's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersEdmonton
Employee Range11
Year Founded2017
Last FundingJun 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?